banner
HIV protease inhibitor BMS 626529, Purity ≥98%

Cat. No.: X24-07-ZQ781

HIV protease inhibitor BMS 626529, Purity ≥98%

Synonym: 701213-36-7; HIV protease inhibitor; BMS-626529; BMS626529

  • MDL: MFCD22665723
  • CAS Number: 701213-36-7
  • Compound CID: 11317439
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
BMS 626529, soluble in DMSO and insoluble in ethanol and water, blocks the protease enzyme, essential for the maturation and replication of HIV, playing a key role in highly active antiretroviral therapy (HAART).
Molecular Weight
473.48
Molecular Formula
C24H23N7O4
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 92 mg/mL (194.3 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
BMS 626529 is investigated for its role in inhibiting HIV protease, providing insights into antiviral therapies.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0